SMTL ID : 4kjy.1 (1 other biounit)

Complex of high-affinity SIRP alpha variant FD6 with CD47

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.93 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: K.6, T.107, I.108 6 PLIP interactions: 1 interactions with chain B, 5 interactions with chain A Water bridges: B:G.59, A:E.106, A:T.107 Hydrogen bonds: A:T.107, A:I.108 Salt bridges: A:K.6

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.32, T.34 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.32 NAG.3: 2 residues within 4Å: Chain A: T.33, N.55 No protein-ligand interaction detected (PLIP) NAG.4: 3 residues within 4Å: Chain A: G.92, N.93, E.110 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.93, A:E.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Weiskopf, K. et al., Engineered SIRP alpha variants as immunotherapeutic adjuvants to anticancer antibodies. Science (2013)

Release Date

2013-06-12

Peptides

Leukocyte surface antigen CD47: A
High-affinity SIRPa variant FD6: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Leukocyte surface antigen CD47

High-affinity SIRPa variant FD6

Related Entries With Identical Sequence